Findings of Misconduct in Science, 4566 [2010-1706]
Download as PDF
<![CDATA[
4566
Federal Register / Vol. 75, No. 18 / Thursday, January 28, 2010 / Notices
funding fee and sales reporting. A
request for public comments was
published in the Federal Register at 74
FR 58630, on November 13, 2009. No
comments were received.
Public comments are particularly
invited on: Whether this collection of
information is necessary and whether it
will have practical utility; whether our
estimate of the public burden of this
collection of information is accurate,
and based on valid assumptions and
methodology; ways to enhance the
quality, utility, and clarity of the
information to be collected.
DATES: Submit comments on or before:
March 1, 2010.
FOR FURTHER INFORMATION CONTACT: Mr.
Warren Blankenship, Procurement
Analyst, Contract Policy Branch, at
telephone (202) 501–1900 or via e-mail
to warren.blankenship@gsa.gov.
ADDRESSES: Submit comments regarding
this burden estimate or any other aspect
of this collection of information,
including suggestions for reducing this
burden to GSA Desk Officer, OMB,
Room 10236, NEOB, Washington, DC
20503, and a copy to the Regulatory
Secretariat (MVPR), General Services
Administration, 1800 F Street, NW.,
Room 4041, Washington, DC 20405.
Please cite OMB Control No. 3090–0121,
Industrial Funding Fee and Sales
Reporting, in all correspondence.
SUPPLEMENTARY INFORMATION:
A. Background
The Government collects the data
quarterly in order to evaluate and
monitor the effectiveness of the
schedule program and to negotiate
better prices based on volume, which
saves taxpayers dollars. As a result of
collecting the data quarterly, the
Government has the ability to provide
upon request current schedule sales
information to the federal agencies and
the public.
mstockstill on DSKH9S0YB1PROD with NOTICES
B. Annual Reporting Burden
Respondents: 17,000.
Responses Per Respondent: 20.
Total Responses: 340,000.
Hours Per Response: .0833.
Total Burden Hours: 28,322.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the General Services Administration,
Regulatory Secretariat (MVPR), 1800 F
Street, NW., Room 4041, Washington,
DC 20405, telephone (202) 208–7312.
Please cite OMB Control No. 3090–0121,
Industrial Funding Fee and Sales
Reporting, in all correspondence.
VerDate Nov<24>2008
17:16 Jan 27, 2010
Jkt 220001
Dated: January 22, 2010.
Al Matera,
Director, Acquisition Policy Division.
[FR Doc. 2010–1681 Filed 1–27–10; 8:45 am]
BILLING CODE 6820–61–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Misconduct in Science
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
SUMMARY: Notice is hereby given that on
January 7, 2010, the Department of
Health and Human Services (HHS)
Debarring Official, on behalf of the
Secretary of HHS, issued a final notice
of debarment based on the misconduct
in science findings of the Office of
Research Integrity (ORI) in the following
case:
James Gary Linn, PhD, Tennessee
State University: Based on the findings
in an investigation report by Tennessee
State University (TSU) and additional
analysis conducted by ORI in its
oversight review, ORI found that James
Gary Linn, Ph.D., former Professor,
School of Nursing, TSU, committed
misconduct in science and research
misconduct in research supported by
National Institute of General Medical
Sciences (NIGMS), National Institutes of
Health (NIH), grant S06 GM008092, and
National Center for Research Resources
(NCRR), NIH, grant G12 RR03033.
Specifically, ORI found:
• The Respondent knowingly and
intentionally falsified and/or fabricated
the data and results of a study in which
he purportedly tested the effects of an
intervention to reduce sexual risk
behaviors in high risk, impaired
populations of homeless men with
mental illness by reporting false values
for variables in Tables 2–5 of Cellular
and Molecular Biology 49(7):1167–1175,
2003. In that published article, he
falsified the values in Tables 2–5 by
altering the values that he had obtained
from another author’s manuscript.
• The Respondent provided a CD
ROM disc to TSU’s Institutional
Research Investigation Committee (RIC)
that he claimed contained files
supporting his analyses for the article in
question but that contained fabricated
and/or falsified data.
• The Respondent submitted falsified
summary data to the TSU RIC during
the TSU investigation and to ORI.
ORI issued a charge letter
enumerating the above findings of
misconduct in science and proposing
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
HHS administrative actions. Dr. Linn
subsequently requested a hearing before
an Administrative Law Judge (ALJ) of
the Departmental Appeals Board to
dispute these findings. However, on
November 30, 2009, Dr. Linn withdrew
his request for a hearing. On December
18, 2009, the ALJ of the Departmental
Appeals Board accepted Dr. Linn’s
withdrawal and dismissedhis request
for a hearing. Thus, the scientific
misconduct findings set forth above
became effective, and the following
administrative actions have been
implemented for a period of three (3)
years, beginning on January 7, 2010:
(1) Dr. Linn has been debarred from
any contracting or subcontracting with
any agency of the United States
Government and from eligibility or
involvement in nonprocurement
programs of the United States
Government referred to as ‘‘covered
transactions’’ pursuant to the
Department of Health and Human
Service’s Implementation (2 CFR Part
376 et seq.) of OMB Guidelines to
Agencies on Governmentwide
Debarment and Suspension, 2 CFR Part
180; and
(2) Dr. Linn is prohibited from serving
in any advisory capacity to PHS
including but not limited to service on
any PHS advisory committee, board,
and/or peer review committee, or as
consultant.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Investigative
Oversight, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8800.
John Dahlberg,
Director, Division of Investigative Oversight,
Office of Research Integrity.
[FR Doc. 2010–1706 Filed 1–27–10; 8:45 am]
BILLING CODE 4160–17–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30 Day 10–0222]
Agency Forms Undergoing Paperwork
Reduction Act Review; Proposed Data
Collections Submitted for Public
Comment and Recommendations;
Correction
AGENCY: Centers for Disease Control and
Prevention.
ACTION: Notice; correction.
SUMMARY: The Centers for Disease
Control and Prevention published a
document in the Federal Register of
E:\FR\FM\28JAN1.SGM
28JAN1
]]>Agencies
[Federal Register Volume 75, Number 18 (Thursday, January 28, 2010)]
[Notices]
[Page 4566]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-1706]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Findings of Misconduct in Science
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that on January 7, 2010, the Department
of Health and Human Services (HHS) Debarring Official, on behalf of the
Secretary of HHS, issued a final notice of debarment based on the
misconduct in science findings of the Office of Research Integrity
(ORI) in the following case:
James Gary Linn, PhD, Tennessee State University: Based on the
findings in an investigation report by Tennessee State University (TSU)
and additional analysis conducted by ORI in its oversight review, ORI
found that James Gary Linn, Ph.D., former Professor, School of Nursing,
TSU, committed misconduct in science and research misconduct in
research supported by National Institute of General Medical Sciences
(NIGMS), National Institutes of Health (NIH), grant S06 GM008092, and
National Center for Research Resources (NCRR), NIH, grant G12 RR03033.
Specifically, ORI found:
The Respondent knowingly and intentionally falsified and/
or fabricated the data and results of a study in which he purportedly
tested the effects of an intervention to reduce sexual risk behaviors
in high risk, impaired populations of homeless men with mental illness
by reporting false values for variables in Tables 2-5 of Cellular and
Molecular Biology 49(7):1167-1175, 2003. In that published article, he
falsified the values in Tables 2-5 by altering the values that he had
obtained from another author's manuscript.
The Respondent provided a CD ROM disc to TSU's
Institutional Research Investigation Committee (RIC) that he claimed
contained files supporting his analyses for the article in question but
that contained fabricated and/or falsified data.
The Respondent submitted falsified summary data to the TSU
RIC during the TSU investigation and to ORI.
ORI issued a charge letter enumerating the above findings of
misconduct in science and proposing HHS administrative actions. Dr.
Linn subsequently requested a hearing before an Administrative Law
Judge (ALJ) of the Departmental Appeals Board to dispute these
findings. However, on November 30, 2009, Dr. Linn withdrew his request
for a hearing. On December 18, 2009, the ALJ of the Departmental
Appeals Board accepted Dr. Linn's withdrawal and dismissedhis request
for a hearing. Thus, the scientific misconduct findings set forth above
became effective, and the following administrative actions have been
implemented for a period of three (3) years, beginning on January 7,
2010:
(1) Dr. Linn has been debarred from any contracting or
subcontracting with any agency of the United States Government and from
eligibility or involvement in nonprocurement programs of the United
States Government referred to as ``covered transactions'' pursuant to
the Department of Health and Human Service's Implementation (2 CFR Part
376 et seq.) of OMB Guidelines to Agencies on Governmentwide Debarment
and Suspension, 2 CFR Part 180; and
(2) Dr. Linn is prohibited from serving in any advisory capacity to
PHS including but not limited to service on any PHS advisory committee,
board, and/or peer review committee, or as consultant.
FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative
Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite
750, Rockville, MD 20852, (240) 453-8800.
John Dahlberg,
Director, Division of Investigative Oversight, Office of Research
Integrity.
[FR Doc. 2010-1706 Filed 1-27-10; 8:45 am]
BILLING CODE 4160-17-P
